Abstract:" We should not moor a ship with one anchor, or our life with one hope " –Epictetus Endoscopic biliary stenting plays a crucial part in the management of patients with malignant biliary strictures (MBSs), not only in a palliative setting where there is metastatic disease, but also in allowing neoadjuvant chemotherapy to be given before surgery [1]. The use of self-expandable metal stents (SEMSs) is preferred to plastic stents, as SEMSs are associated with a longer patient survival, a lower risk of stent dysfunction/cholangitis, and fewer reinterventions [1]. Fully covered SEMSs (FCSEMSs) have the advantage of being less prone to obstruction owing to tissue ingrowth, which allows easier stent removal; on the other hand, migration, into the duodenal lumen or even in an intrabiliary direction, can be of a major concern [2]. Neoadjuvant chemotherapy seems to be an additional risk factor that favors migration, which relates to the reduction in tumoral tissue [3]. Another debatable concern with the use of FCSEMSs is the incidence of cholecystitis, especially in patients presenting with tumor involvement of the cystic duct [3]. "... the advantage of an externally anchored plastic stent is the maintenance of biliary drainage by the plastic stent if it remains in the original position, even after migration of the FCSEMS." In the current issue of Endoscopy , Chun et al. demonstrate a novel technique to mitigate migration of FCSEMSs, with the aid of a 7-Fr pigtail plastic stent anchored externally [4]. In this multicenter retrospective study including 185 patients with distal MBSs, mostly due to pancreatic cancer, 65 patients had an FCSEMS alone, and 120 had an FCSEMS with an external plastic stent. Stent patency was defined as the time between placement of the stent and stent revision owing to any stent dysfunction attributable to migration or occlusion, or other causes requiring reintervention The median stent patency was significantly longer in the group with an FCSEMS with an external plastic stent than in the FCSEMS only group (342 vs. 240 days; P = 0.04). Moreover, the rate of stent migration was significantly lower in the FCSEMS with an external plastic stent group than in the FCSEMS only group (10.8 % vs. 27.7 %; P = 0.01). The use of an external plastic stent was associated with stent patency in a multivariate analysis. Nevertheless, there were no significant differences regarding the need for reintervention for stent revision and the occurrence of adverse events (AEs). Specifically, the incidence of cholecystitis was 6.4 %, with no significant difference between the two groups. The same authors have recently reported that anchoring with a 7-Fr double-pigtail stent inside an FCSEMS prevented stent migration and prolonged stent patency compared with an FCSEMS alone in a randomized controlled trial (RCT) [5]. Although both techniques have similar antimigration efficacy, the advantage of an externally anchored plastic stent is the maintenance of biliary drainage by the plastic stent if it remains in the original position, even after migration of the FCSEMS. Indeed, in the current study, among the patients in the FCSEMS with an external plastic stent group whose FCSEMS migrated, the plastic stent remained in the original position for most patients, therefore ensuring ongoing biliary drainage. Although the described technique seems to be an elegant and affordable way to prevent migration of FCSEMSs, the debate is still open regarding the choice between uncovered SEMSs (USEMSs), partially covered SEMSs (PCSEMSs), or FCSEMSs. A multicenter RCT of 119 patients with MBS due to pancreatic cancer receiving neoadjuvant chemotherapy that compared FCSEMSs and USEMSs showed an equal sustained biliary drainage (72.2 % vs. 72.9 %) [3]. Tumor ingrowth was observed in 0 % vs. 16.7 % ( P < 0.01) and stent migration in 6 % vs. 0 % ( P = 0.03). Acute cholecystitis rates did not differ significantly between the two groups (9.3 % [4/43] for FCSEMSs vs. 4.8 % [2/42] for USEMSs; P = 0.08). Finally, predictors of failure to decompress a biliary obstruction were the use of shorter SEMSs (4-cm long compared with 6- and 8-cm long) and the presence of the gallbladder, but not the type of stent. Another RCT, including 158 patients with MBS due to inoperable pancreatic cancer and therefore mostly receiving palliative chemotherapy, also compared FCSEMSs with USEMSs [6]. FCSEMSs had a lower stent patency (240 vs. 541 days for USEMSs; P = 0.03) and were associated with more stent-related AEs as measured by stent dysfunction (overall AEs were 26.4 % for FCSEMSs vs. 13.2 % for USEMSs, although this was not statistically significant). FCSEMS dysfunction included migration and early occlusi -Abstract Truncated-

Usefulness of half-covered metallic stent placement in preventing acute cholecystitis complication in pancreatic cancer-induced distal biliary stricture

Big End Double-Layer Stents for the Treatment of Gastric Outlet Obstruction Caused by Stomach Cancer

Feasibility of Double-Deployment Small-Diameter Covered Metallic Stent for Malignant Distal Biliary Obstruction (with Video)

Outcomes of multi-hole self-expandable metal stents versus fully covered self-expandable metal stents for malignant distal biliary obstruction in unresectable pancreatic cancer

Usefulness of Intraductal Placement of a Dumbbell-Shaped Fully Covered Self-Expandable Metal Stent for Post-Cholecystectomy Bile Leaks

Safety of biliary drainage with 6‐mm metallic stent for preoperative obstructive jaundice in pancreatic cancer: PURPLE SIX STUDY

Development of Severe Acute Pancreatitis Following Uncovered Metallic Stent Placement: A Rare Case Report

Endoscopic Sphincterotomy Associated Cholangitis in Patients Receiving Proximal Biliary Self-Expanding Metal Stents.

A Case Series: Outcomes of Endoscopic Biliary Self-Expandable Metal Stent for Malignant Biliary Obstruction with Surgically Altered Anatomy

Covered self-expandable metallic stent versus plastic stent for preoperative endoscopic biliary drainage in patients with pancreatic cancer: a multi-center retrospective cohort study

Risk factors and treatment strategies for cholecystitis after metallic stent placement for malignant biliary obstruction: a multicenter retrospective study

Endoscopic Placement of a Covered Self-Expandable Metal Stent in the Minor Papilla in Patients with Chronic Pancreatitis and Pancreas Divisum

Cholecystitis in patients with a fully covered self-expandable metal stent with and without externally anchored plastic stents

Randomized multicenter study of multiple plastic stents vs. covered self-expandable metallic stent in the treatment of biliary stricture in chronic pancreatitis

S1617 Post-ERCP Cholecystitis Following Covered Self-Expandable Metal Stent Placement in Patients With Malignant Biliary Obstruction: A Meta-Analysis

Comparison of an Inside Stent and a Fully Covered Self-Expandable Metallic Stent as Preoperative Biliary Drainage for Patients with Resectable Perihilar Cholangiocarcinoma

S1658 Risk Factors for Cholecystitis After Self-Expandable Metallic Stent Placement for Malignant Distal Biliary Obstruction: A Systematic Review and Meta-Analysis

Efficacy and safety of a novel polytetrafluoroethylene-coated self-expandable metal stent for distal malignant biliary obstruction

Endoscopic Self-Expandable Metal Stent Placement for Malignant Afferent Loop Obstruction After Pancreaticoduodenectomy: A Case Series and Review

Efficacy and safety of covered versus uncovered self‑expandable metal stents for the palliative treatment of malignant distal biliary stricture: A long‑term retrospective study

Optimizing biliary stenting in patients with distal malignant biliary obstruction